Viekira $3B+ in 4Q annual rate sale is quite realistic.
Note that $3B+ in 4Q15 is not what ABBV has told investors; rather, ABBV had guided for a >$3B annualized run rate by the end of 2015.
V-Pak sales could conceivably hit $3B in 4Q15 if Japan contributes a full quarter, but such an outcome would be well ahead of ABBV’s guidance.
p.s. There seems to be some disparity wrt the 2Q15 consensus V-Pak sales figure. @TylerHCanalyst (a reliable source, IMO) tweeted that the consensus was $402M (vs ISI’s $431M).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.